Us Bancorp »

Artiva Biotherapeutics shares owned by Us Bancorp

Quarter-by-quarter ownership of Artiva Biotherapeutics (ARTV) shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Artiva Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Artiva Biotherapeutics held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Artiva Biotherapeutics by Us Bancorp

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.3k 235 9.70

More positions owned by Us Bancorp

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core Msci Eafe (IEFA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)
Ishares Core Msci Emkt (IEMG)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Mid Cap Etf (VO)
NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Ishares Tr Rus Mid Cap Etf (IWR)
JPMorgan Chase & Co. (JPM)

View all positions for Us Bancorp

Top funds holding Artiva Biotherapeutics

RA Capital Management
Viking Global Investors
Blackstone Group
5AM Venture Management
VR Adviser
Franklin Resources
Caligan Partners
Vanguard Capital Management
Samsara BioCapital
Blue Owl Capital Holdings
Propel Bio Management
BlackRock
Citadel Advisors
Silverarc Capital Management
Geode Capital Management

View all funds holding Artiva Biotherapeutics